Ingrid Delaet Net Worth & Insider Trades

Ingrid Delaet - Chief Regulatory Officer, Neurocrine Biosciences Inc

As of August 30, 2023

What is Ingrid Delaet's Net Worth?

The current estimated net worth of Neurocrine Biosciences Inc's Chief Regulatory Officer, Ingrid Delaet, is estimated to be about $833.75K . Ingrid Delaet owns about 5,931 units of Neurocrine Biosciences Inc common stock. In the last 7 months at Neurocrine Biosciences Inc, Ingrid Delaet has sold an estimated value of $304.68K worth.

What is Ingrid Delaet's Past Insider Trading?

Ingrid Delaet's largest sale order was 1,431 units , worth over $153.86K on August 30, 2023. In total, Ingrid Delaet has made about 3 transactions over 7 months of their time at Neurocrine Biosciences Inc. Ingrid Delaet usually trades in August, with the busiest year in 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Ingrid Delaet

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Ingrid Delaet's' Mailing Address?

  • Mailing address is C/o Neurocrine Biosciences, Inc. 12780 el Camino Real San Diego CA 92130 CA

Neurocrine Biosciences Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Stock Awards
Other Compensation
Total
Kevin C. Gorman, Ph.D. 2018 $675,000 $425,250 $4,486,852 $2,998,832 $47,045 $8,632,979
Kevin C. Gorman, Ph.D. 2019 $725,000 $667,000 $6,000,525 $2,000,071 $58,230 $9,450,826
Kevin C. Gorman, Ph.D. 2020 $775,000 $542,500 $7,124,633 $5,375,188 $63,311 $13,880,632
Matthew C. Abernethy 2018 $420,000 $199,500 - $1,996,506 $69,741 $2,685,747
Matthew C. Abernethy 2019 $495,600 $284,970 $3,750,345 $1,250,035 $42,170 $5,823,120
Matthew C. Abernethy 2020 $545,200 $190,820 $2,999,869 $2,500,266 $45,021 $6,281,176
Eric Benevich 2018 $432,600 $205,485 $1,496,335 $1,499,417 $38,768 $3,672,605
Eric Benevich 2019 $467,200 $280,320 $3,750,345 $1,250,035 $45,547 $5,793,447
Eric Benevich 2020 $499,900 $199,960 $2,999,869 $3,000,257 $48,974 $6,748,960
Kyle W. Gano, Ph.D. 2018 $403,100 $191,473 $1,309,024 $2,656,575 $8,069 $4,568,241
Kyle W. Gano, Ph.D. 2019 $443,400 $266,040 $3,000,285 $1,000,076 $16,171 $4,725,972
Kyle W. Gano, Ph.D. 2020 $487,700 $207,273 $3,749,799 $2,750,210 $16,751 $7,211,733
Eiry W. Roberts, M.D. 2018 $490,700 $220,800 $2,863,700 $4,053,869 $671,554 $8,300,623
Eiry W. Roberts, M.D. 2019 $538,200 $309,465 $3,000,285 $1,000,076 $51,889 $4,899,915
Eiry W. Roberts, M.D. 2020 $575,900 $215,963 $2,624,855 $2,375,242 $56,073 $5,848,033
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/914475/000119312521111693/d87247ddef14a.htm

What are Neurocrine Biosciences Inc's Past Insider Trades?

Neurocrine Biosciences Inc's most recent insider trade came on November 29, 2023 by Darin Lippoldt who sold 10,919 units worth $1.23M . In the last 20 years, insiders at Neurocrine Biosciences Inc have sold an estimated value of $410.2M and bought an estimated value of $68.14M worth of shares. Insider trading is most common in February, with the busiest year in 2017. The most active traders at the company are Dimitri Grigoriadis, Chief Research Officer,  Gary Lyons, Director,  and Haig Bozigian, Chief Development Officer .

NEUROCRINE BIOSCIENCES INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...